ARCA
in the News
“I am very confident in my clean & sober future now, more so
than I have ever been in prior attempts at ridding myself of this
devastating disorder.” Former
Assisted Recovery Client <more>
Setting
a New Benchmark for Treating Addictions......................
Assisted Recovery
Detox & Rehab Overview
Call
Assisted Recovery's
24-Hour Help Line
(314) 645-6840
for a free, confidential consultation.
Located in St. Louis, MO
...
“Assisted Recovery's unique program, combining
therapy with FDA-approved medication, has been most successful.”
Former Assisted Recovery Client <more>
TYPES OF
ADDICTIONS
Alcohol Dependence/Alcoholism
............................................................
Pain
Pills / Heroin / Opiates
............................................................
Cocaine
............................................................
Prescription
Drugs
............................................................
Smoking
............................................................
Gambling
............................................................
Resources
............................................................
Myths
of Addiction
............................................................
ASSISTED RECOVERY NEWS & EVENTS
This section will have your current:
-
Newscasts, Interviews & Video
-
Published Articles / Journals
-
Press Releases
-
Events
-
Newsletters
Treatment / Rehab
» Detox
» Outpatient
» Residential
» HealthPro Program
» Ready for Help?
Therapies & Medications
» Evidence-Based
Integrated Treatment
» Counseling:
Individual & Group
» Dual Diagnosis
» Vivitrol®
» Naltrexone
» Cognitive
Behavioral Therapy
(CBT)
Setting a New Benchmark for Treaing Addicitions
Alcohol/Drug Detox & Rehab. FDA approved Anti-Craving Medications. Alternative to 12-Step & Methadone Treatment
Clinical Trial for
Healthcare Professionals with Opioid Dependence
A.E. Daniel, MD with Assisted Recovery Centers of America, LLC (ARCA) is looking for healthcare professionals with opioid dependence to participate in a clinical trial. You must be detoxed from opioids and wish to be treated with an opioid antagonist, a drug that prevents you from feeling the effect of opiates.
VIVITROL® is a medication
currently approved for the treatment of alcoholism. This two-year study
will assess VIVITROL’s® efficacy and tolerability in the treatment
of health care professionals with opiate dependence. Participants will receive
a monthly injection of VIVITROL® for up to 24 months and will complete
three questionnaires about daily functioning, satisfaction with treatment,
and opioid craving during the visits.
You must be enrolled in an outpatient recovery program and/or receiving
regular counseling and able to participate for up to two years. If you are
a female, you must use adequate contraception. The sponsor will pay for
study related medical care, lab work and examinations, and study medication.
Protection of your confidentiality is a priority for our staff. You
may receive compensation for time and travel.
For more information, please call:
Dr. A.E. Daniel at: 573-443-6930
or
ARCA at: 314-645-6840
